These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 36205914)

  • 21. Role of molecular chaperones in neurodegenerative disorders.
    Meriin AB; Sherman MY
    Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mechanistic insight into protein-ligand interaction, folding, misfolding, aggregation and inhibition of protein aggregates: An overview.
    Chandel TI; Zaman M; Khan MV; Ali M; Rabbani G; Ishtikhar M; Khan RH
    Int J Biol Macromol; 2018 Jan; 106():1115-1129. PubMed ID: 28890370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases.
    Crippa V; Carra S; Rusmini P; Sau D; Bolzoni E; Bendotti C; De Biasi S; Poletti A
    Autophagy; 2010 Oct; 6(7):958-60. PubMed ID: 20699640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial sequestration of misfolded proteins in neurodegenerative diseases.
    Rolli S; Sontag EM
    Biochem Soc Trans; 2022 Apr; 50(2):759-771. PubMed ID: 35311889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 14-3-3 and aggresome formation: implications in neurodegenerative diseases.
    Jia B; Wu Y; Zhou Y
    Prion; 2014; 8(2):173-7. PubMed ID: 24549097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging Methods for Structural Analysis of Protein Aggregation.
    Khan E; Mishra SK; Kumar A
    Protein Pept Lett; 2017; 24(4):331-339. PubMed ID: 28176657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting DNA topoisomerases or checkpoint kinases results in an overload of chaperone systems, triggering aggregation of a metastable subproteome.
    Huiting W; Dekker SL; van der Lienden JCJ; Mergener R; Musskopf MK; Furtado GV; Gerrits E; Coit D; Oghbaie M; Di Stefano LH; Schepers H; van Waarde-Verhagen MAWH; Couzijn S; Barazzuol L; LaCava J; Kampinga HH; Bergink S
    Elife; 2022 Feb; 11():. PubMed ID: 35200138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PolyQ-expanded proteins impair cellular proteostasis of ataxin-3 through sequestering the co-chaperone HSJ1 into aggregates.
    Yue HW; Hong JY; Zhang SX; Jiang LL; Hu HY
    Sci Rep; 2021 Apr; 11(1):7815. PubMed ID: 33837238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Misfolded Protein Linked Strategies Toward Biomarker Development for Neurodegenerative Diseases.
    Kumar S; Karthikeyan N; Mishra S; Padmanabhan P; Radda G; Gulyás B
    Mol Neurobiol; 2019 Apr; 56(4):2559-2578. PubMed ID: 30043261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence Linking Protein Misfolding to Quality Control in Progressive Neurodegenerative Diseases.
    Kabir MT; Uddin MS; Abdeen A; Ashraf GM; Perveen A; Hafeez A; Bin-Jumah MN; Abdel-Daim MM
    Curr Top Med Chem; 2020; 20(23):2025-2043. PubMed ID: 32552649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From molecular dynamics to quantum mechanics of misfolded proteins and amyloid-like macroaggregates applied to neurodegenerative diseases.
    Gillet JN
    J Mol Graph Model; 2022 Jan; 110():108046. PubMed ID: 34736057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of microRNAs by IRE1α in apoptosis: implications for the pathomechanism of neurodegenerative diseases.
    Su Z; Sheng L; Yu P; Ren N; Li Y; Qin Z
    Int J Neurosci; 2020 Dec; 130(12):1230-1236. PubMed ID: 32070174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive review of protein misfolding disorders, underlying mechanism, clinical diagnosis, and therapeutic strategies.
    Basha S; Mukunda DC; Rodrigues J; Gail D'Souza M; Gangadharan G; Pai AR; Mahato KK
    Ageing Res Rev; 2023 Sep; 90():102017. PubMed ID: 37468112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The therapeutic potential of chemical chaperones in protein folding diseases.
    Cortez L; Sim V
    Prion; 2014; 8(2):197-202. PubMed ID: 24818993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aptamers Targeting Hallmark Proteins of Neurodegeneration.
    Mollasalehi N; Francois-Moutal L; Porciani D; Burke DH; Khanna M
    Nucleic Acid Ther; 2022 Aug; 32(4):235-250. PubMed ID: 35452303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein aggregation and neurodegenerative diseases: From theory to therapy.
    Kumar V; Sami N; Kashav T; Islam A; Ahmad F; Hassan MI
    Eur J Med Chem; 2016 Nov; 124():1105-1120. PubMed ID: 27486076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion-Like Protein Aggregates and Type 2 Diabetes.
    Mukherjee A; Soto C
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28159831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using Single-Molecule Fluorescence Microscopy to Uncover Neuronal Vulnerability to Protein Damage.
    Jacob-Tomas S; Alagar Boopathy LR; Vera M
    Methods Mol Biol; 2022; 2515():237-254. PubMed ID: 35776356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osmolytes: A Possible Therapeutic Molecule for Ameliorating the Neurodegeneration Caused by Protein Misfolding and Aggregation.
    Kushwah N; Jain V; Yadav D
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31941036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.